Trade Mark Journal No.2025/024 13 June 2025

WO0000001856843 (5)

Office of origin: United States of America

Date of International Registration:18 April 2025
Date of designation in the UK: 18 April 2025
Image for mark 1856843 JIDEYTRO

International priority date claimed: 27 November 2024 (United States of America) (98876370)
Class 5
Pharmaceutical preparations and pharmaceutical products for use in oncology diseases and disorders.

Nuvalent, Inc.

Representative: Joshua S. Jarvis Foley Hoag LLP, 155 Seaport Blvd., Boston MA 02210-2600, UNITED STATES OF AMERICA